See also this year's filing and all EDGAR filings for this company.
PDF Report 0001070494_2019_Acadia_Pharmaceuticals_INC.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': inf, 'aggregate_val': 223807000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}} |
Graph
Absolute values for 0001070494, Acadia Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 526,106,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 4,062,000 |
| 2 | PropertyPlantAndEquipmentNet | 3,309,000 |
| 3 | remainder_Assets | 6,725,000 |
| 4 | LiabilitiesCurrent | 59,565,000 |
| 5 | LiabilitiesNoncurrent | 1,558,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 293,531,423 |
| 9 | ResearchAndDevelopmentExpense | 319,554,226 |
| 10 | remainder_Expenses | 57,568,679 |
| 11 | remainder_Revenues | 716,110,830 |
| 12 | remainder_NetIncome | 6,871,495 |
| 13 | remainder_ComprehensiveNetIncome | -455,287 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 540,202,000 |
| 1 | Liabilities | 61,123,000 |
| 2 | Expenses | 670,654,328 |
| 3 | Revenues | 716,110,830 |
| 4 | StockholdersEquity | 479,079,000 |
| 5 | NetIncome | 52,327,997 |
| 6 | ComprehensiveNetIncome | 52,100,354 |
| 7 | BaseVar | 997,708,470 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.65 |
| 9 | EconomicCapitalRatio | 4.13 |
Edgar->Model Mapping
Feature Distribution
Change over Time
